Dyspareunia is the clinical term for pain during and/or after intercourse and is often a symptom of Atrophic Vaganitis – most commonly associated with the menopause. Dyspareunia can also be caused by pain in the perineal region caused by scarring or a traumatic childbirth.
Due to the lack of oestrogen, atrophic vaginas lack elasticity and can be dry and unlubricated. This can make sexual intercourse painful. The pain can be superficial, affecting the opening of the vulva, or it can be felt deep within the pelvis.
Dyspareunia can cause women both physical and emotional distress and have a negative effect on a woman’s mental wellbeing and their intimate relationships.
If you have painful intercourse, you might feel:
To find out more about how the Regenerative Clinic can treat symptoms of Dyspareunia and to see whether this might be the right treatment for you, book a consultation with one of our consultant gynaecologists. For more information about the procedure and aftercare please visit our FAQ page.
“I feel since having this treatment at The Regenerative Clinic that I have been given back my dignity as a woman.“
J.B – Lichen Sclerosus age 60
“I have started to feel as though a burden has been lifted and my emotional well-being has considerably improved.”
N.S – Lichen Sclerosus age 47
Abstract: Urogenital atrophy is a degenerative process that may occur during menopause causing debilitating disorders and painful symptomatology. Estrogen therapy slows the onset of atrophy, but it requires ongoing therapy to maintain its effectiveness. To mitigate the degenerative evolutions associated with menopause, patients may benefit from new therapeutic approaches, such as the use of mesenchymal stem cells. Among the many sources, the adipose tissue is considered one of the smartest, due to its abundance and easy access. This study investigated the feasibility and potential benefits of using an autologous adipose tissue to treat the symptoms of urogenital atrophy
Introduction: Reproductive tissues are now recognised as sources of stem/progenitor cells and as targets for regenerative medicine. This paper briefly reviews the progress and future challenges of applying regenerative medicine to the urogenital tract and the use of stem cells for the treatment of inherited genetic diseases, especially those with irreversible perinatal damage. Stem cells sourced from reproductive tissues have been used or investigated for their potential use in other areas such as haematological disease, traditionally treated with haematopoietic stem cells (HSC) from adult sources but for which toxic adjuvant treatments, or bone tissue engineering, are concurrently needed.1 However, applications of such methods, together with the use of stem cells for gamete generation, are beyond the scope of this paper.
Wound healing is a complex physiological process including overlapping phases (hemostatic/inflammatory, proliferating and remodeling phases). Every alteration in this mechanism might lead to pathological conditions of different medical relevance. Treatments for chronic non-healing wounds are expensive because reiterative treatments are needed. Regenerative medicine and in particular mesenchymal stem cells approach is emerging as new potential clinical application in wound healing.
In the past decades, advance in the understanding of molecular mechanisms underlying wound healing process has led to extensive topical administration of growth factors as part of wound care. Currently, no definitive treatment is available and the research on optimal wound care depends upon the efficacy and cost-benefit of emerging therapies.
Here we provide an overview on the novel approaches through stem cell therapy to improve cutaneous wound healing, with a focus on diabetic wounds and Systemic Sclerosis-associated ulcers, which are particularly challenging. Current and future treatment approaches are discussed with an emphasis on recent advances.
Comprehensive regenerative medicine policy framework to spur innovation, efficient access to potentially transformative products, while ensuring safety & efficacy.
Lipo-modeling is the process of relocating autologous fat to change the shape, volume, consistency, and profile of tissues, with the aim of reconstructing, rejuvenating, and regenerating body features. There have been several important advancements in Lipo-modeling procedures during the last thirty years. Four clinical steps are important for the success of engraftment: fat harvesting, fat processing, fat re-injection, and pre-conditioning of the recipient site. With the discovery of adipose derived stem cells and de-differentiated cells, fat cells become a major tool of regenerative medicine. This article reviews recent trends in lipo-modeling trying to understand most of the issues in this field.
“My special interest is in the menopause as I am one of those ladies who has gone through that and I have seen and felt myself, what problems it brings.
For women at this age, their vagina and vulva can be affected by the decrease of hormones and they can often tell me that they do not wish to have any further sexual intercourse and this is because of the dryness and pain experienced.
The new technique, which I am excited about is our Lipogems® treatment. It has been used for painful joints (orthopaedics) in over 30,000 patients by extracting repair cells or Mesenchymal stem cells and seeing joint pain decrease. We have also seen great benefits for postmenopausal women by restoring vaginal health.
We have seen the significant benefits of their postmenopausal symptoms and also how it worked in other ways which we didn’t expect for example, for urinary stress incontinence.”